Pharmaceutical company Sanofi Aventis reported Wednesday a 6 percent increase in second quarter net profit, due to stronger sales of its diabetes drug Lantus and blood Thinners Lovenox and Plavix, which it predicted would boost full year earnings.
Sanofi Aventis Q6 profit up 6 percent.